Rachel M. Locklin

1.1k total citations
20 papers, 896 citations indexed

About

Rachel M. Locklin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Rachel M. Locklin has authored 20 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Rachel M. Locklin's work include Bone health and treatments (7 papers), Mesenchymal stem cell research (5 papers) and Bone health and osteoporosis research (4 papers). Rachel M. Locklin is often cited by papers focused on Bone health and treatments (7 papers), Mesenchymal stem cell research (5 papers) and Bone health and osteoporosis research (4 papers). Rachel M. Locklin collaborates with scholars based in United Kingdom, United States and New Zealand. Rachel M. Locklin's co-authors include James T. Triffitt, Sundeep Khosla, B. Lawrence Riggs, Russell T. Turner, Veraragavan P. Eswarakumar, Mark C. Horowitz, Peter Lonai, Gillian Morriss‐Kay, Richard O. C. Oreffo and Zhidao Xia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Journal of Bone and Mineral Research.

In The Last Decade

Rachel M. Locklin

20 papers receiving 873 citations

Peers

Countries citing papers authored by Rachel M. Locklin

Since Specialization

Citations

This map shows the geographic impact of Rachel M. Locklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Locklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Locklin more than expected).

Fields of papers citing papers by Rachel M. Locklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel M. Locklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Locklin. The network helps show where Rachel M. Locklin may publish in the future.

Co-authorship network of co-authors of Rachel M. Locklin

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel M. Locklin. A scholar is included among the top collaborators of Rachel M. Locklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel M. Locklin. Rachel M. Locklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced osteoblastogenesis in three-dimensional collagen gels 2014 ·BoneKEy Reports ·Brya G. Matthews, Dorit Naot, Karen E. Callon, David S. Musson, Rachel M. Locklin, P A Hulley, Andrew Grey, Jillian Cornish	28
2	Evidence ofcis-acting regulatory variation inPTPN22in patients with rheumatoid arthritis 2012 ·Scandinavian Journal of Rheumatology ·Pille Harrison, Lorraine Southam, K Chapman, Rachel M. Locklin, A Sabokbar, B. P. Wordsworth, J. J. Pointon	3
3	Differences between bisphosphonates in binding affinities for hydroxyapatite 2009 ·Journal of Biomedical Materials Research Part B Applied Biomaterials ·Michelle A. Lawson, Zhidao Xia, B.L. Barnett, James T. Triffitt, Roger Phipps, James E. Dunford, Rachel M. Locklin, Frank H. Ebetino, R.G.G. Russell	97
4	Lactoferrin protects osteoblasts and osteocytes from apoptosis 2009 ·Bone ·Rachel M. Locklin, P A Hulley, Dorit Naot, Jillian Cornish	1
5	Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice 2008 ·European Journal of Cell Biology ·Zhidao Xia, Rachel M. Locklin, James T. Triffitt	8
6	Evaluation of the relative mineral-binding affinities of clinically-relevant bisphosphonates by using hydroxyapatite-column chromatography and adsorption isotherms combined with mass spectrometric analysis 2008 ·Bone ·Zhidao Xia, Xuchen Duan, Rachel M. Locklin, Mike Quijano, Roy L. M. Dobson, James T. Triffitt, Frank H. Ebetino, R.G.G. Russell	3
7	Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment 2007 ·Leukemia ·Rachel M. Locklin, Peter I. Croucher, R.G.G. Russell, Claire M. Edwards	17
8	Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis 2007 ·Molecular Cancer Therapeutics ·Rachel M. Locklin, Ermanno Federici, (unknown), P A Hulley, R.G.G. Russell, Claire M. Edwards	25
9	LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis 2006 ·Arthritis & Rheumatism ·Claire M. Edwards, Sanyuan Sun, Rachel M. Locklin, C M Shipman, Iannis E. Adamopoulos, N. A. Athanasou, A Sabokbar	78
10	Stimulation of osteoclast formation by inflammatory synovial fluid 2006 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Iannis E. Adamopoulos, Lynett Danks, Ichiro Itonaga, Rachel M. Locklin, Afsie Sabokbar, David Ferguson, Nicholas A. Athanasou	18
11	Innate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice 2006 ·Journal of Cellular Biochemistry ·Zhidao Xia, Philip R. Taylor, Rachel M. Locklin, Siamon Gordon, Zhanfeng Cui, James T. Triffitt	23
12	Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2 2005 ·Journal of Bone and Mineral Research ·Rachel M. Locklin, Ermanno Federici, Peter I. Croucher, R.G.G. Russell, C M Shipman	1
13	Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography. 2005 ·Oxford University Research Archive (ORA) (University of Oxford) ·Michelle A. Lawson, J T Triffitt, Frank H. Ebetino, B.L. Barnett, Roger Phipps, Rachel M. Locklin, R.G.G. Russell	5
14	Efficient characterisation of human cell–bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells 2005 ·Biomaterials ·Zhidao Xia, Hua Ye, Rachel M. Locklin, David Ferguson, Zhanfeng Cui, James T. Triffitt	23
15	A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis 2004 ·Proceedings of the National Academy of Sciences ·Veraragavan P. Eswarakumar, Mark C. Horowitz, Rachel M. Locklin, Gillian Morriss‐Kay, Peter Lonai	170
16	Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone 2003 ·Journal of Cellular Biochemistry ·Rachel M. Locklin, Sundeep Khosla, Russell T. Turner, B. Lawrence Riggs	159
17	Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology 2001 ·Journal of Bone and Mineral Research ·Rachel M. Locklin, B. Lawrence Riggs, K. C. Hicok, Heidi F. Horton, Michael C. Byrne, Sundeep Khosla	75
18	Effects of TGFβ and BFGF on the differentiation of human bone marrow stromal fibroblasts 1999 ·Cell Biology International ·Rachel M. Locklin, Richard O. C. Oreffo, James T. Triffitt	69
19	MODULATION OF OSTEOGENIC DIFFERENTIATION IN HUMAN SKELETAL CELLS IN VITRO BY 5‐AZACYTIDINE 1998 ·Cell Biology International ·Rachel M. Locklin, Richard O. C. Oreffo, James T. Triffitt	29
20	In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. 1995 ·PubMed ·Rachel M. Locklin, (unknown), J.N. Beresford, J T Triffitt, Maureen Owen	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact